Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2016 Dec 21;3(4):e189.
doi: 10.14309/crj.2016.162. eCollection 2016 Aug.

A Bleeding Duodenal GIST Masquerading as Refractory Peptic Ulcer Disease

Affiliations
Case Reports

A Bleeding Duodenal GIST Masquerading as Refractory Peptic Ulcer Disease

Jason D Jones et al. ACG Case Rep J. .

Abstract

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract; however, the occurrence of a GIST in the duodenum is rare. Our case demonstrates the importance of considering GIST in the evaluation of refractory duodenal ulcers, as well as the utilization of endoscopic ultrasound in the evaluation of these lesions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Contrast-enhanced computed tomography scan showing the junction of the second and third portion of the duodenum (arrow) without evidence of mass lesion.
Figure 2
Figure 2
Endoscopic appearance of 8-mm superficial ulcer in the second portion of the duodenum.
Figure 3
Figure 3
Endoscopic ultrasound revealing a 9.6 x 13 mm oval, hypoechoic, homogeneous mass in the second portion of the duodenum arising from the muscularis propria (arrow).
Figure 4
Figure 4
Duodenal sections reveal (A) a well-circumscribed tumor in the muscularis propria (4x) and (B) bland spindle cell proliferation (40x). No pronounced pleomorphism, necrosis, or increased mitotic activity noted.
Figure 5
Figure 5
Immunohistochemical staining revealed that the neoplastic cells were intensely and diffusely positive for CD117, which supports the diagnosis of GI stromal tumor (2x).

References

    1. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg. 2000; 231(1):51–8. - PMC - PubMed
    1. Besana-Ciani I, Boni L, Dionigi G, et al. . Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST). Scand J Surg. 2003; 92(3):195–9. - PubMed
    1. Badalamenti G, Rodolico V, Fulfaro F, et al. . Gastrointestinal stromal tumors (GISTs): Focus on histopathological diagnosis and biomolecular features. Ann Oncol. 2007; 18(6):vi136–40. - PubMed
    1. Stamatakos M, Douzinas E, Stefanaki C, et al. . Gastrointestinal stromal tumor. World J Surg Oncol. 2009; 7:61.. - PMC - PubMed
    1. Motegi A, Sakurai S, Nakayama H, et al. . PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT‐negative tumors. Pathol Int. 2005; 55(3):106–12. - PubMed

Publication types